Precursors to this disease include DCIS and LCIS. The PARP inhibitor iniparib failed in a trial to treat this disease. A particularly aggressive form of this disease results in the affected organ taking on an "orange peel" appearance. A monoclonal antibody to HER2/neu, called Herceptin, was originally developed to treat this disease. Genetic susceptibility to this disease is conferred by mutations in BRCA1 and 2. This disease can be classified by
Precursors to this disease include DCIS and LCIS. The PARP inhibitor iniparib failed in a trial to treat this disease. A particularly aggressive form of this disease results in the affected organ taking on an "orange peel" appearance. A monoclonal antibody to HER2/neu, called Herceptin, was originally developed to treat this disease. Genetic susceptibility to this disease is conferred by mutations in BRCA1 and 2. This disease can be classified by its expression of ErbB-2, progesterone (*) receptor, and estrogen receptor. It is subdivided into conditions of ductal and lobular origin. This disease is screened for using mammograms and self-exams. For 10 points, name this type of cancer that is usually treated with a mastectomy and radiation.
Precursors to this disease include DCIS and LCIS. The PARP inhibitor iniparib failed in a trial to treat this disease.
breast cancer [prompt on "cancer"]